Distribution, characterization, and induction of CD8+ regulatory T cells and IL-17-producing CD8+ T cells in nasopharyngeal carcinoma

Table 1 Sample information

No.	Gender	Age (yr)	Histological type^a	WHO classification^b	Clinical stage
NPC1	F	52	III	T3N1M0	III
NPC2	M	29	III	T2N2M0	III
NPC3	M	53	III	T3N0M0	III
NPC4	M	45	III	T4N2M0	IVA
NPC5	M	46	III	T4N1M0	IVA
NPC6	M	47	III	T2N0M0	II
NPC7	M	63	III	T4N2M0	IVA
NPC8	M	36	III	T3N1M0	III
NPC9	M	44	III	T3N1M0	III
NPC10	F	29	III	T2N2M0	III
NPC11	M	38	III	T2N2M0	III
NPC12	F	31	III	T3N2M0	III
NPC13	M	39	III	T3N2M0	III
NPC14	F	25	III	T3N1M0	III
NPC15	M	38	III	T3N2M0	III
NPC16	M	34	III	T3N1M0	III
NPC17	M	38	III	T3N2M0	III
NPC18	M	42	III	T3N1M0	III
NPC19	M	30	III	T3N2M1	IVA
NPC20	M	54	III	T2N1M0	II
NPC21	M	56	III	T2N2M0	IVA

^aHistological type: I = differentiated keratinizing squamous cell carcinoma; II = differentiated nonkeratinizing carcinoma; III = undifferentiated carcinoma. ^bTNM stage according to WHO UICC-AJCC 1997 standards (International Union Against Cancer/American Joint Committee on Cancer)

ISSN: 1479-5876